Paxlovid is an antiviral combination therapy that can reduce the risk of COVID-19 causing severe illness, hospitalization and ...

“Some people think that if they got the vaccine or feel healthy, they don’t need treatment,” said Karyne Jones, President and CEO of NCBA, Inc. and co-convener of CVEEP. “But that’s not always true.

Researchers have described the optimal timing for COVID-19 patients to take the antiviral, Paxlovid, to get the most benefit from the treatment, according to a study published April 16 in eLife.

The Front Line COVID-19 Critical Care Alliance (FLCCC) lists about 20 medications, vitamins and therapies as part of its "i-recover" protocol for long COVID-19, with ivermectin at the top of the list.

He had heard of a new coronavirus treatment -- like the one President Donald Trump was given during his bout with COVID-19. The treatment of lab-created monoclonal antibodies is meant to be used ...

The data from this prospective cohort study confirm and expand previous retrospective case series that have found factors, including hematologic cancers, chemotherapy receipt, and lung cancer, as ...

If an EUA amendment for COVID-19 treatment is granted, Invivyd intends to assess the virologic profile of pemivibart in a clinical study designed in collaboration with the FDA.

In 2020, then-President Donald Trump said he had been taking hydroxychloroquine to prevent a COVID-19 infection, despite warnings by the U.S. Food and Drug Administration over its effectiveness.

COVID-19 has not revealed its secrets or how we might best treat it. This study suggests that metformin's unexpected role in curbing the severity of the virus, coupled with its ability to reduce viral ...

During the current "silent" COVID-19 surge, you are at greater risk for getting infected with the SARS-CoV-2. ... Paxlovid is one of the two oral antivirals available for Covid-19 treatment.

Although we may not hear much about it these days, long COVID-19 is still out there. In the beginning, treatment seemed to be a hit-and-miss, but the approach has had a breakthrough.

When it comes to navigating COVID-19, knowledge is power. The more we share information about COVID-19 treatment options, the more we can build a collective sense of resilience and readiness.